« Previous
Next »
Artery Research
Volume 3, Issue 1
, Pages 17-23
, February 2009
A haplotype at the MMP-9 locus is associated with high-blood pressure and arterial stiffness in patients with essential hypertension
References
- Prognostic value of aortic pulse wave velocity as index of arterial stiffness in the general population. Circulation. 2006;113:664–670
- Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients. Hypertension. 2001;37:1236–1241
- Aortic stiffness is an independent predictor of fatal stroke in essential hypertension. Stroke. 2003;34:1203–1206
- . Impact of aortic stiffness attenuation on survival of patients in end-stage renal failure. Circulation. 2001;103:987–992
- Central pulse pressure and mortality in end-stage renal disease. Hypertension. 2002;39:735–738
- . Arterial wave reflections and survival in end-stage renal failure. Hypertension. 2001;38:434–438
- Arterial stiffness, wave reflections, and the risk of coronary artery disease. Circulation. 2004;109:184–189
- . Matrix metalloproteinases: regulation and dysregulation in the failing heart. Circ Res. 2002;90:520–530
- Inflammation in atherosclerosis: visualizing matrix metalloproteinase action in macrophages in vivo. Circulation. 2006;114:55–62
- Expression of matrix metalloproteinases and endogenous inhibitors within ascending aortic aneurysms of patients with Marfan syndrome. Circulation. 2006;114:365–370
- . Elevated matrix metalloproteinase expression after stent implantation is associated with restenosis. Int J Cardiol. 2006;112:85–90
- Matrix metalloproteinase-9 (MMP-9), MMP-2, and serum elastase activity are associated with systolic hypertension and arterial stiffness. Arterioscler Thromb Vasc Biol. 2005;25:372–378
- Antidiabetic PPAR gamma-activator rosiglitazone reduces MMP-9 serum levels in type 2 diabetic patients with coronary artery disease. Arterioscler Thromb Vasc Biol. 2003;23:283–288
- Circulating matrix metalloproteinases and their inhibitors in premature coronary atherosclerosis. Clin Chem Lab Med. 2001;39:380–384
- Plasma concentrations and genetic variation of matrix metalloproteinase 9 and prognosis of patients with cardiovascular disease. Circulation. 2003;107:1579–1585
- Functional polymorphism in the regulatory region of gelatinase B gene in relation to severity of coronary atherosclerosis. Circulation. 1999;99:1788–1794
- . Haplotypic analysis of the MMP-9 gene in relation to coronary artery disease. J Mol Med. 2003;81:321–326
- . Matrix metalloproteinase-9 genotype influences large artery stiffness through effects on aortic gene and protein expression. Arterioscler Thromb Vasc Biol. 2004;24:1479–1484
- Variation in the human matrix metalloproteinase-9 gene is associated with arterial stiffness in healthy individuals. Arterioscler Thromb Vasc Biol. 2006;26:1799–1805
- . Matrix metalloproteinase-9 polymorphism contributes to blood pressure and arterial stiffness in essential hypertension. J Hum Hypertens. 2007;21(11):861–867
- . Binding of gelatinases A and B to type-I collagen and other matrix components. Biochem J. 1995;309:299–306
- . Identification of structural elements important for matrix metalloproteinase type V collagenolytic activity as revealed by chimeric enzymes. Role of fibronectin-like domain and active site of gelatinase B. J Biol Chem. 2000;275:27964–27972
- . Association study of polymorphisms within matrix metalloproteinase 9 with bronchial asthma. Int J Immunogenet. 2005;32:233–236
- . Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics. 2005;21:263–265
- . Score tests for association between traits and haplotypes when linkage phase is ambiguous. Am J Hum Genet. 2002;70:425–434
- Aortic stiffness is an independent predictor of primary coronary events in hypertensive patients: a longitudinal study. Hypertension. 2002;39:10–15
- Matrix metalloproteinase-2, and 9 and tissue inhibitor of metalloprotaienase-1 in patients with hypertension. Endothelium. 2006;13:227–231
- Targeted deletion of matrix metalloproteinase-9 attenuates left ventricular enlargement and collagen accumulation after experimental myocardial infarction. J Clin Invest. 2000;106:55–62
- Loss of matrix metalloproteinase-9 or matrix metalloproteinase-12 protects apolipoprotein E-deficient mice against atherosclerotic media destruction but differentially affects plaque growth. Circulation. 2004;109:1408–1414
- . Targeted disruption of the matrix metalloproteinase-9 gene impairs smooth muscle cell migration and geometrical arterial remodeling. Circ Res. 2002;91:852–859
- . The predictive power of haplotypes in clinical response. Pharmacogenomics. 2000;1:15–26
- . Detecting disease associations due to linkage disequilibrium using haplotype tags: a class of tests and the determinants of statistical power. Hum Hered. 2003;56:18–31
PII: S1872-9312(09)00003-9
doi: 10.1016/j.artres.2009.01.002
© 2009 Association for Research into Arterial Structure and Physiology. Published by Elsevier Inc. All rights reserved.
« Previous
Next »
Artery Research
Volume 3, Issue 1
, Pages 17-23
, February 2009
